The invasive heart procedure meant to prevent strokes in atrial fibrillation patients may be performed far more frequently than clinical evidence supports, raising concerns about unnecessary medical interventions in cardiovascular care. Left atrial appendage closure involves implanting a device to seal off a small heart chamber where blood clots commonly form in patients with irregular heartbeats. This mechanical intervention theoretically reduces stroke risk by preventing clot formation, but emerging scrutiny questions whether the procedure's risks and costs justify its expanding use. The intervention requires cardiac catheterization, device implantation, and ongoing anticoagulation therapy, creating a complex treatment cascade that may not always benefit patients optimally. This editorial commentary reflects growing awareness within cardiology about procedure creep—the tendency for interventions to expand beyond their evidence-based indications. Similar patterns have emerged with other cardiac devices and procedures, where initial promising results in carefully selected patients led to broader application without proportional benefit verification. The appendage closure debate highlights fundamental tensions in modern cardiology between technological capabilities and patient outcomes. For health-conscious adults with atrial fibrillation, this discussion underscores the importance of seeking multiple opinions before agreeing to invasive procedures. The commentary suggests that medication-based anticoagulation therapy may remain the gold standard for most patients, despite the appeal of a 'one-time fix' device solution. This represents incremental but important progress in medical self-regulation, where specialists increasingly question their own field's tendency toward intervention.